Ethics Governance
Ethics & Governance - Resources and Articles |
| Articles indexes: a | b | c | d | e | f | g | h | i | j | k | l | m | n | o | p | q | r | s | t | u | v | w | x | y | z | other | |
|
|
| Article - Abstract. To view full article click on the article title. | |
eMJA: Commens, Truth in clinical research trials involving pharmaceutical sponsorship Truth in clinical research trials involving pharmaceutical sponsorship Large clinical trials are expensive to mount. Funding comes mainly from pharmaceutical companies seeking information on drug efficacy and adverse events. Patients should be informed of the financial and publication agreements reached between those conducting the trials. This is unlikely to have a significant effect on trial participation and will provide patients with information relevant to informed consent. A small proportion of monies raised from drug trials could be set aside to fund both a trial register site and further studies on adverse drug reactions. Chris A Commens MJA 2001; 174: 648-649. In recent years, economic rationalism has forced public institutions to look for non-governmental sources of income and links with industry.1 Our dermatology department needed equipment for which funds were not available from the hospital budget, but would be available from payment for participating in a drug trial. The trial sponsors wished to compare their product with the current "best" cream and a placebo in a randomised controlled trial. Participation would be voluntary, the risk of harm minimal, privacy would be protected and patients would be "suitably informed". An administrative and financial agreement was arranged between our department and the professional contract research organisation responsible for the study. Full Article: http://www.mja.com.au/public/issues/174_12_180601/commens/commens.html |
|
2006 Ethics-Governance.com |
|||